SOLSSolstice Advanced Materials, Inc.
Is the business good?
The checks split: nothing decisive, though 3 of 9 health tests passed.
Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.
A balanced mix of margins, efficiency, and leverage. ROE 13% = margin × turnover × leverage.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is SOLS?
Solstice Advanced Materials, Inc. keeps 5.1% of every revenue dollar as profit after everything, against 4.7% for the median Specialty Chemicals name.
Net margin · Specialty Chemicals median 4.7% · 12 months to Q2 2026
- Share count, year on year
- +0.44%
Share count, year on year · flat: no meaningful dilution
- R&D as % of revenue
- 2.6%
R&D as % of revenue
- Gross margin
- 31%
Gross margin
Details›
- Gross margin12 months to Q2 2026
- 31%
- Net margin12 months to Q2 2026
- 5.1%
- Free cash flow margin
- 4.8%
- R&D as % of revenue
- 2.6%
- Revenue, trailing twelve months
- $4.09B
- Free cash flow, trailing twelve months
- $195M
- Net income, trailing twelve months
- $210M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Customers and suppliers
Who buys from SOLS and who it buys from, as the companies report it.
- 10 largest customers18%
Combined share of revenue · FY2025 10-K
None disclosed.
A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; SOLS’s own figures are from its FY2025 10-K. Smaller customers and suppliers go unreported.
Specialty Chemicals
The closest names by size in the same industry